PLYXPolaryx Therapeutics Inc. Common Stock
2.070USD-4.17%Mkt Cap: 98.00M $P/E: —3d ago
Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the Un…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap98.00M $
Enterprise Value95.13M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.98M $
Revenue/Share—
Last Price2.070 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B9.77
EPS (TTM)-0.13
EPS (Forward)—
52W Range
1.8700% of range48.91
52W High48.91 USD
52W Low1.870 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-196.82%
ROA-173.79%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.94M $
CapEx (TTM)—
FCF Margin—
FCF Yield-2.13%
Net Debt-11.54M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio13.53
Quick Ratio13.22
Book Value/Sh0.2190 USD
Cash/Share0.2320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.500 USD
Upside (mean)+262.3%
Target Range6.000 USD – 10.00 USD
$6.000+262.3% to mean$10.00
# Analysts4
Ownership
Shares Out.47.34M
Float6.78M
Insiders69.92%
Institutions4.40%
Short Interest
Short Ratio2.4d
Short % Float1.19%
Short % Out.0.52%
Shares Short256.77K
Short (prev mo.)408.52K
Technical
SMA 502.308 (-10.3%)
SMA 2004.246 (-51.2%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)105.69K
Avg Vol (10d)126.32K
Technical Indicators
RSI (14)43.3
MACD-0.0512
MACD Signal-0.0493
MACD Hist.-0.0018
BB Upper2.501 USD
BB Middle2.188 USD
BB Lower1.874 USD
BB Width28.62%
ATR (14)0.2320 USD
Vol Ratio (20d)0.95x